tiprankstipranks
Trending News
More News >
Sellas Life Sciences Group (SLS)
:SLS
US Market

SELLAS Life Sciences Group (SLS) Income Statement

Compare
1,169 Followers

SELLAS Life Sciences Group Income Statement

Last quarter (Q3 2025), SELLAS Life Sciences Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, SELLAS Life Sciences Group's net income was $-6.79M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 7.60M$ 1.90M
Gross Profit
$ 0.00$ 0.00$ 900.00K$ 7.40M$ 1.90M
Operating Expenses
$ 31.51M$ 37.87M$ 42.85M$ 32.69M$ 18.88M
Depreciation and Amortization
$ 31.51M$ 37.87M$ 457.00K$ 1.27M$ 377.00K
EBITDA
$ 632.00K$ 529.00K$ -31.49M$ -18.32M$ -16.40M
Operating Income
$ -31.51M$ -37.87M$ -41.95M$ -25.29M$ -16.98M
Other Income/Expenses
$ 632.00K$ 529.00K$ 649.00K$ 4.36M$ 208.00K
Pretax Income
$ -30.88M$ -37.34M$ -41.30M$ -20.94M$ -16.77M
Net Income
$ -30.88M$ -37.34M$ -41.30M$ -20.70M$ -16.76M
Per Share Metrics
Basic EPS
$ -0.05$ -0.15$ -2.13$ -1.34$ -2.11
Diluted EPS
$ -0.05$ -0.15$ -2.13$ -1.34$ -2.11
Weighted Average Shares Outstanding
612.02M 249.99M 19.40M 15.48M 7.98M
Weighted Average Shares Outstanding (Diluted)
612.02M 249.99M 19.40M 15.48M 7.98M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History